You are here: Industry Insights > BioNTech

News List

‘Mix and match’ COVID-19 vaccine study yields promising results pharmatimes
June 30, 2021
A study evaluating a mix and match approach to COVID-19 vaccinations has found that using a different jab for the first and second doses gives good protection against the virus.
Pfizer says COVID vaccine is highly effective against Delta variant expresspharma
June 28, 2021
First identified in India, Delta is becoming the globally dominant variant of the coronavirus, according to the World Health Organization.
mRNA-based therapeutic cancer vaccine enters Phase II trial europeanpharmaceuticalreview
June 24, 2021
BioNTech is evaluating its investigational therapeutic mRNA-based cancer vaccine, BNT111, in combination with Libtayo® (cemiplimab) for the treatment of melanoma.
Siemens and BioNTech expand their collaboration for global vaccine production firstwordpharma
June 24, 2021
Siemens supplies the latest automation and digitalization technology for the production of Covid-19 vaccines
Novartis aims to bottle more than 50 mln doses of BioNTech COVID-19 vaccine in 2021 firstwordpharma
June 23, 2021
Novartis aims to bottle more than 50 million doses of BioNTech’s COVID-19 vaccine this year at its fill-and-finish facility in Stein, Switzerland, as reported in KFGO.
Comirnaty® COVID-19 vaccine protects against multiple viral variants europeanpharmaceuticalreview
June 16, 2021
Laboratory study shows the blood sera of people vaccinated against COVID-19 with Comirnaty® can neutralise at least six viral variants including three variants of concern.
Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation contractpharma
June 11, 2021
Pfizer Inc. and BioNTech SE plan to provide the U.S. government at a not-for-profit price 500 million doses of the companies’ COVID-19 vaccine, 200 million doses in 2021 and 300 million doses in 1H22.
MHRA authorises Pfizer/BioNTech’s COVID-19 vaccine for 12- to 15-year-olds pharmatimes
June 08, 2021
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has extended the authorisation of Pfizer/BioNTech’s COVID-19 vaccine for use in children aged 12 to 15 years old.
Covid-19 vaccines show efficacy in adolescents, paving path towards herd immunity pharmaceutical-technology
June 08, 2021
There are globally now more people vaccinated for COVID-19 than confirmed cases of COVID-19. With globally over 400 million people fully vaccinated and over 1.7 billion vaccine doses administered, herd immunity seems achievable.
Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine contractpharma
June 08, 2021
Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page